0001354457-23-000646.txt : 20230908
0001354457-23-000646.hdr.sgml : 20230908
20230908100901
ACCESSION NUMBER: 0001354457-23-000646
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230908
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: AMYRIS, INC.
CENTRAL INDEX KEY: 0001365916
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 550856151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34885
BUSINESS ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-0761
MAIL ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC
DATE OF NAME CHANGE: 20060613
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001365916
AMYRIS, INC.
001-34885
5885 Hollis Street, Suite 100
Emeryville
CA
CALIFORNIA
94608
510-450-0761
Common stock
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2023-09-08
EX-99.25
2
amrsdelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC, September 8, 2023,
Amyris, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the common stock of Amyris, Inc. (the Company),
effective at the opening of the trading session on September 18, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5101, 5110(b), and IM-5101-1.
The Company was notified of the Staff determination on
August 10, 2023. The Company did not appeal the Staff determination
to the Hearings Panel. The Company securities were suspended on
August 21, 2023. The Staff determination to delist the Company
securities became final on August 21, 2023.